Treatment for impetigo

British Journal of General Practice

Volumn 53, Issue 497, 2003, Pages 974-

  Brown, Erwin ^a   Wise, Richard ^b  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FUSIDIC ACID; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; IMPETIGO; LETTER; META ANALYSIS; MICROBIOLOGICAL PARAMETERS; PRACTICE GUIDELINE; PRESCRIPTION; SEPSIS; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMPETIGO; META-ANALYSIS; MUPIROCIN;

EID: 0348162408     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. George A, Rubin G. A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract 2003; 53: 480-487.
2. Brown EM, Wise R. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint [Letter]. BMJ 2002; 324: 1394.
3. Sule O, Brown N, Brown DFJ, Burrows N. Fusidic acid cream for impetigo. Judicious use is advisable [Letter]. BMJ 2002; 324: 1394.
4. Weston VC, Boswell TCJ, Finch RG, Perkins W. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use [Letter]. BMJ 2002; 324: 1394.
5. Riley TV, Carson CF, Bowman RA et al. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1999; 161: 397-398.
6. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western Australia. Infect Control Hosp Epidemiol 1999; 20: 133-135.